bumetanide 1 MG Oral Tablet
bumetanide
RxCUI: 197418
What the CMS Formulary Data Shows for bumetanide 1 MG Oral Tablet
Per the CMS 2026 Part D formulary file, bumetanide 1 MG Oral Tablet (RxNorm concept RXCUI 197418, generic name bumetanide) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.
Real-world access to bumetanide 1 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 522,275 Part D beneficiaries filled bumetanide 1 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $98,372,371 and an average per-beneficiary annual cost of $188.35. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry bumetanide 1 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 522,275
- Total spending
- $98,372,371
- Avg per beneficiary
- $188.35
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering bumetanide 1 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is bumetanide 1 MG Oral Tablet covered by Medicare Part D?
Yes, bumetanide 1 MG Oral Tablet is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is bumetanide 1 MG Oral Tablet on Medicare Part D plans?
bumetanide 1 MG Oral Tablet averages Tier 2 across Part D plans, ranging from Tier 1 to Tier 6.
Does bumetanide 1 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for bumetanide 1 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on bumetanide 1 MG Oral Tablet?
In 2023, total Medicare Part D spending on bumetanide 1 MG Oral Tablet was $98,372,371, covering 522,275 beneficiaries. The average spend per beneficiary was $188.35.
Read our methodology - how this data is sourced, computed, and verified.